According to MeiraGTx's latest financial reports the company has a price-to-book ratio of 2.33.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.23 | 20.36% |
2022-12-31 | 2.68 | -52.83% |
2021-12-31 | 5.69 | 102.95% |
2020-12-31 | 2.80 | -27.35% |
2019-12-31 | 3.86 | 18.53% |
2018-12-31 | 3.26 | |
2017-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Organovo ONVO | 1.90 | -18.44% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 4.74 | 103.53% | ๐ฌ๐ง UK |
Novavax NVAX | -0.9655 | -141.49% | ๐บ๐ธ USA |
Novocure
NVCR | 4.39 | 88.56% | Jersey |